Interview With Alternative Cancer Doctor Nicholas Gonzalez

This is an interview of noted cancer specialist Nicholas Gonzalez by Joseph Mercola.  Dr. Gonzalez uses a system of metabolic typing diets, juicing, coffee enemas to detox colon and liver and very high doses of pancreatic enzymes.  The history of the development of this story is fascinating.  

Dr. Mercola's Comments:

Alternative cancer treatments are a kind of "forbidden area" in medicine, but Dr. Gonzalez chose to go that route anyway, and has some remarkable success stories to show for his pioneering work.
He didn't set out to treat cancer at first however, let alone treat patients. His original plan was to be a basic science researcher at Sloan-Kettering; a teaching hospital for Cornell Medical College. He had a chance meeting with William Kelley, a controversial dentist who was one of the founders of nutritional typing. Dr. Kelley had been practicing alternative- and nutritional approaches for over two decades at the time, led him to begin a student project investigation of Kelley's work, in the summer of 1981.

"I started going through his records and even though I was just a second year medical student, I could see right away there were cases that were extraordinary," he says. "Patients with appropriately diagnosed pancreatic cancer, metastatic breast cancer in the bone, metastatic colorectal cancer… who were alive 5, 10, 15 years later under Kelley's care with a nutritional approach."

This preliminary review led to a formal research study, which Dr. Gonzalez completed while doing his fellowship in cancer, immunology and bone marrow transplantation.

The "Impossible" Recoveries of Dr. Kelley's Cancer Patients

After going through thousands of Kelley's records, Dr. Gonzalez put together a monograph, divided into three sections:

1. Kelley’s theory
2. 50 cases of appropriately-diagnosed lethal cancer patients still alive five to 15 years after diagnosis, whose long-term survival was attributed to Kelley’s program
3. Patients Kelley had treated with pancreatic cancer between the years 1974 and 1982

According to Dr. Good, the president of Sloan-Kettering who had become Gonzalez' mentor, if Kelley could produce even one patient with appropriately diagnosed pancreatic cancer who was alive 5-10 years later, it would be remarkable. They ultimately tracked down 22 of Kelley's cases. Ten of them met him once and didn't do the program after being dissuaded by family members or doctors who thought Kelley was a quack.
The average survival for that group was about 60 days.
A second group of seven patients who did the therapy partially and incompletely (again, dissuaded by well-intentioned but misguided family members or doctors), had an average survival of 300 days.
The third group consisting of five patients, who were appropriately diagnosed with advanced pancreatic cancer and who completed the full program, had an average survival of eight and a half years! In Dr. Gonzalez' words, this was "just unheard of in medicine."
One of those patients included a woman diagnosed by the Mayo Clinic with stage four pancreatic cancer who had been given six months to live. She'd learned about Kelley's program through a local health food store. She completed his treatment and is still alive today, 29 years later.

Total Video Length: 1:42:22
Download Interview Transcript

In looking around the internet I found a clinic that gives a basic rundown of what Dr. Gonzalez is doing.
http://www.aspenintegrativemedicine.com/?q=node/49

Dr. Kelley's original book is online here
http://www.drkelley.com/CANLIVER55.html







 

Meats Not To Eat

You might have missed the media headlines last month which extolled hotdogs as better for you than chicken. If you click on the Time Magazine link above you can get a taste of this nonsense. This is a perfect example of how taking too narrow-minded a view can lead you astray from the truth about what's healthy and what's not.
Here, the researchers measured several different types of meats for levels of heterocyclic amines (HCAs), and because hot dogs and pepperoni happened to have lower levels of HCAs than rotisserie chicken, MSNBC leapt to the conclusion that these processed meats are better for you because they're "relatively free of carcinogenic compounds."
WRONG! They're just relatively lower in ONE type of carcinogenic compound! But hot dogs and other processed meats contain OTHER compounds that put them squarely on the list of foods to avoid or eliminate entirely...

Researchers Create Better Ways to Spot Cancer Cells

Cancer can be notoriously difficult to spot, so scientists are working to develop new techniques to better detect tumors in the body. Such tools could potentially identify cancer cells more reliably and earlier than currently available methods, such as mammography, biopsies and magnetic resonance imaging, or MRI. Improved detection methods could help speed up treatment decisions and monitor whether a therapy is working.

The Root Cause of Cancer Almost Universally Ignored by Doctors...

In 1971 President Nixon and Congress declared war on cancer. So what's happened in the 40 years since? After weeding out the hype and filling in the actual statistics, it turns out, not much.

"These summary statistics show that the war on cancer has not gone well," says the article's author, Reynold Spector. "This is in marked contrast to death rates from stroke and cardiovascular disease (adjusted for the age and size of the population), which have fallen by 74 percent and 64 percent, respectively, from 1950 through 2006; and by 60 percent and 52 percent, respectively, from 1975 through 2006 (Kolata 2009a).
Cancer therapy is clearly decades behind."

Further down the article.  Dr. Mercola writes:  

Getting to the Root of the Problem

I strongly believe the cancer rates are escalating because they are in no way shape or form addressing the underlying cause of most cancers. Instead, most of the research is directed towards expensive drugs that target late stages of the disease and greatly enrich the drug companies but simply do not prevent cancer.
If ever there was an area in which an ounce of prevention is worth a pound of cure it is cancer. I strongly believe that if you are able to work your way up to the advanced health plan, that you will virtually eliminate the risk of most cancers.
Environmental- and lifestyle factors are increasingly being pinpointed as the primary culprits fueling our cancer epidemic.

 

Association of Integrative Oncology and Chinese Medicine

I and colleagues from many parts of the world are interested in creating a Society of Chinese Medicine practitioners interested in Integrative Oncology.  The endeavor to bring this Society to life is about creating community, and organizing standards and competencies and then teaching to those standards. 

For more information about the AIOCM click here. 

Mechanism for Link Between High Fat Diet and Risk of Prostate Cancer and Disorders Unveiled

ScienceDaily (July 16, 2010) — Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009. Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer.

Sanjay Gupta, MS, PhD, Carter Kissell associate professor & research director in the Department of Urology and associate professor in the Department of Nutrition in the Case Western Reserve School of Medicine, and his team of post-doctoral fellows have focused on understanding the mechanisms of the deleterious effects of a high fat diet on the prostate. Previously, Dr. Gupta's team demonstrated that nuclear factor kappa B (NF-κB), a protein complex that controls DNA transcription which is activated as a result of inflammation and stress, is constitutively activate in human prostate adenocarcinoma and is related to tumor progression (Shukla S et al, Neoplasia, 2004).
In a new study published in the journal The Prostate, Dr. Gupta and his team demonstrate that a high fat diet results in activation of NF-κB in the abdominal cavity, thymus, spleen, and prostate. Non-obese NF-κB reporter mice were fed a high fat diet for four, eight, and 12 weeks. Compared with mice fed a regular diet, the high fat diet group had significant increases in prostate weight, and in the prostate expression of markers of oxidative stress (such as NADPH), and inflammation (such as the downstream targets of NF-κB: nitric oxide synthase, and cyclooxygenase [COX-2]) were increased. These studies provide direct evidence that a high fat diet causes proliferation, inflammation, and oxidative stress that can lead to benign prostatic hyperplasia, prostatitis, and cancer of the prostate, some of the most common disorders affecting adult men.
"Our studies provide evidence that a high-fat diet increases the activation of NF-κB along with elevated levels of NADPH oxidase components which might lead to intraprostatic inflammation. This study strengthens the link between a high-fat diet -- typical of "Western style" high fat diet -- as a potential cause of prostatic diseases including BPG and prostate cancer," said Dr. Gupta.
This work was supported by grants from the National Cancer Institute, the National Center for Complementary and Alternative Medicine, and the Sullivan Foundation for the Study of Prostatitis.

Alex's note:  There are plenty of natural products to control NF-κB 

CHANGING LIFESTYLE CHANGES GENE EXPRESSION A Talk with Dean Ornish

[DEAN ORNISH:] For the last 30 years or so, I have directed a series of clinical research studies proving that the simple choices that we make in our lives each day can have a powerful impact on our health and our well being, and much more quickly than had once been thought possible, even at a cellular level. Ironically, we have been using very high tech, expensive, state of the art measures to prove how powerful very simple and low tech and often ancient interventions can be.


Our prostate study was a randomized control trial of men who had biopsy proven prostate cancer and who have elected not to be treated conventionally for reasons unrelated to our study. What made this interesting from a scientific standpoint is that we could take men who knew they had cancer from biopsies, randomly divide them into two groups, and have a true non-intervention control group so we could determine the effects of comprehensive lifestyle changes alone without being confounded by other treatments. You can't do that with breast cancer because almost everybody gets treated right away, so you don't know if any improvements were due to the lifestyle changes or the chemo or the radiation or the surgery.
After a year we found that PSA levels, a marker for prostate cancer, went up (worsened) in the comparison or control group, but went down significantly (improved) in the experimental group that made the lifestyle changes we recommended. The degree of change in lifestyle was directly correlated with the degree of change in their PSA levels.
We also found that the prostate tumor growth in vitro was inhibited 70 percent in the group that made these changes compared to only nine percent in the group that didn't. The inhibition of the tumor growth was itself a direct function of the degree of change in lifestyle. In other words, the more people changed, the more it directly inhibited the growth of their prostate tumors.
J. Craig Venter has shown that one way you can change your genes is by making new ones. We are finding that another way you can change your gene expression is simply by changing your lifestyle.
In May of this year, we published an article in the Proceedings of the National Academy of Sciences (Craig was the communicating editor). We found that changing lifestyle actually changes gene expression. In only three months, we found that over 500 genes were either up-regulated or down-regulated—in simple terms, turning on genes that prevent many chronic diseases, and turning off genes that cause coronary heart disease, oncogenes that are linked to breast and prostate cancer, genes that promote inflammation and oxidative stress and so on. 

Is Cancer a Man Made Disease?

Alex's note:  This group of articles I found on one hand disturbing and on the other enlightening.  Wow!  This is the toxic world we live in! But there is a lot we can do to prevent cancer and that is the important take away message.  Once you need heroic measures like chemo. and radiation things have progressed.  It is always better to cut the grass while it is still short.  However since my grass was not cut that way (I got cancer).  It has become a life transforming event and I am dedicated to understanding cancer and its prevention.

A study of ancient bodies has determined that cancer is a man-made disease, one fueled by the excesses. Tumors turn out to be extremely rare until very recent times, when pollution and poor diet became issues.
Researchers analyzed potential references to the disease in classical literature, and also searched for signs in the fossil record and in mummified bodies. But despite examining tissue from hundreds of Egyptian mummies, they confirmed only one case of cancer
According to the Daily Mail:

"Dismissing the argument that the ancient Egyptians didn't live long enough to develop cancer, the researchers pointed out that other age-related disease such as hardening of the arteries and brittle bones did occur ...
Fossil evidence of cancer is also sparse, with scientific literature providing a few dozen, mostly disputed, examples in animal fossil".

Sources:

  Daily Mail October 15, 2010

  Nature Reviews Cancer October 2010; 10: 728-733

  Cancer September 1977; 40(3): 1358-1362

Utilizing Chinese Medicines to Improve Cancer Therapy - Fiction or Reality?

Click here to see the abstracts of the entire journal is devoted to the use of Chinese Medicine in modern Oncology. 

Authors: Sing Sum Chow, Moses; Huang, Ying
Source: Current Drug Discovery Technologies, Volume 7, Number 1, March 2010 , pp. 1-1(1)
Publisher: Bentham Science Publishers

Abstract:
Despite the tremendous effort on research and development by government and industry, effective treatment of cancer in most patients remains elusive at present. Even if a given chemotherapeutic regimen is very effective at onset, it eventually will fail, due to drug resistance and /or organ toxicity. Thus, there is a great need to incorporate new mode of therapeutic approach in prevention and treatment of cancer. Chinese medicines (CM) have been used in China for about 5000 years for symptomatic treatment of diseases including cancer. The traditional approach of CM is to use different herbal formulae to restore the balance of Yin-Yang of body energy so body function can be normalized. Can this traditional Chinese medicine (TCM) approach provide an alternative to the evidence based conventional cancer chemotherapy? It would be a fiction to expect TCM to substitute as an alternative approach to modern cancer chemotherapy, despite its thousands of years of use in China. However, there are distinct potentials, from theory to herbal compounds, which could be derived from CM. For example, the balance concept of TCM may be an intriguing therapeutic approach for future cancer therapy— aiming not to eradicate all cancer cells but to keep it in balance with normal cells to result in bodily function as close to normal as possible and maintain in such a state as long as possible. Another potential contribution of TCM is its rich source of active anticancer compounds and their combinations which could be developed and proved to be effective therapeutic regimens (or adjunctive regimens) in the future. In tracing the source of new drugs for cancer, more than half of current anticancer agents used clinically in USA are either natural occurring or derived from natural products. These include Vinca alkaloids, taxanes, podophyllotoxin, camptothecins and anthracyclines. Despite the interest in plant-based new drug discovery, only a small portion of more than 250,000 known plant species have been investigated for cancer drug discovery. It is likely that herbs used in TCM can be a useful source of new anticancer drugs. Furthermore, the TCM formulae themselves (which always composed of mixtures of components) may simultaneously target multiple cancer-causing genes/pathways and thus achieve superior effect as compared to single agents aiming for a single molecular target. Nevertheless, before any TCM product can be accepted by the Western world as complementary and alternative medicine for cancer treatment/prevention, it is crucial to identify bioactive components, understand their pharmacological mechanisms, and achieve quality control of a given product along with demonstrating its clinical efficacy. In this issue of Current Drug Discovery Technologies, eight review articles highlighting in more detail some of these important points relating to development of CM as anti-cancer drugs. These articles describe the potential use of the balance concept, examples of CM-derived drugs that have been approved by US FDA and new technology (chemoinformatics) and targets (drug transporters and other molecular targets) as well as TCM products and formulations used for lung cancer. We hope that this special issue will provide a glimpse of examples and new technologies that can be applied toward improving the development of CM, potentially leading to new and effective anti-cancer agents in the future.

Document Type: Research article

Click here to see the abstracts of the entire journal is devoted to the use of Chinese Medicine in modern Oncology. 

Lymphoma, Chemotherapy, & Antioxidants

INTRODUCTION
Oxidative stress is defined as a type of physiological stress on the body caused by the damage done by free radicals inadequately neutralized by antioxidants. It has long been known that oxidative stress is an essential mechanism by which chemotherapy works to treat cancer. However, the question of whether this is always the case is seldom debated openly. Taking a deeper look into the research literature yields many examples where oxidative stress on cancer cells has been shown to be counterproductive. For example, a study using human Burkitt lymphoma cells found that oxidative stress actually interferes with the ability of the chemotherapy drugs doxorubicin, cisplatin, etoposide, and cytarabine to cause cancer cell death.
When oxidative stress levels are reduced in cancer cells, their growth is more easily controlled through a process called apoptosis. During apoptosis, cells are removed by the immune system before they lose their cell wall, thus avoiding an inflammatory response to the dying cells.
However, when oxidative stress levels go up, cancer cell death happens through a slower, messier, and less effective pathway called pyknosis or necrosis. Additionally, the ability of the body to “clean up” the resulting cellular debris from cancer cell death is also inhibited by oxidative stress. The body’s house-cleaning cells (called monocyte-derived macrophages) cannot function optimally under conditions of oxidative stress (i.e. low oxygen levels).
The authors of the above-mentioned study on Burkitt lymphoma cells and chemotherapy suggest that including antioxidants in the treatment protocol may enhance chemotherapy-induced apoptosis and phagocytosis. (Shacter, Williams et al. 2000) A second study, involving the chemotherapy drugs etoposide and calcimycin, confirms this finding: Human Burkitt’s lymphoma cells were unable to die quickly by apoptosis in the presence of oxidative stress and instead died using the slower and messier method of necrosis. In this study, it was found that oxidative stress inhibited apoptosis by depleting cells of their energy source, which is called adenosine triphosphate (ATP). (Lee and Shacter 1999)
Related to these observations about the relationship between cellular oxidative stress levels is the widely held view in medicine that the use of antioxidant dietary supplements diminishes chemotherapy’s effectiveness. However, when one looks more closely at the existing published science on how antioxidants and chemotherapy combine, the true answer is not so definitive. Many research studies, encompassing cell culture tests in the laboratory and also animal and some human studies, are coming to a conclusion often very different from the conventional perspective that chemotherapy and antioxidants should never be combined.
One example is a human study in which researchers discovered that higher levels of the antioxidant selenium in the blood of patients with aggressive B-cell non-Hodgkin’s lymphoma correlated with increased achievable doses of anthracycline based chemotherapy, better treatment response, achievement of long term remission, and longer overall survival. It is important to note that in this study, however, the level of selenium present in the blood of patients was from their diet; the study was not a test of supplemented selenium. (Last, Cornelius et al. 2003) As seen in this study, higher levels of natural antioxidants can help treatment outcomes.
On the other hand, the decreased levels of antioxidants (or oxidative stress) that are caused by many chemotherapy treatments correlates with increased side effects. In patients with Hodgkin’s lymphoma, chemotherapy with Adriamycin, bleomycin, vincristine, and dexamethasone significantly decreases antioxidant levels. (Kaya, Keskin et al. 2005) In children with acute lymphoblastic leukemia who received high-dose methotrexate, oxidative damage to proteins as well as other factors was related to toxic side effects. (Carmine, Evans et al. 1995)
Using antioxidants during chemotherapy is an important and controversial question among health care providers, patients, and their support teams. In previous issues of Avenues, we have researched this subject thoroughly for prostate, breast, lung, colon, and ovarian cancers. In this article, we turn our focus to lymphoma, conducting a systematic search for published research that would support or discourage the use of antioxidants in combination with chemotherapy. The overwhelming majority of studies find a favorable interaction between antioxidants and chemotherapy, providing evidence that antioxidants can decrease chemotherapy side effects, increase treatment effectiveness, and decrease resistance to chemotherapy.
For this paper, we searched for clinical or laboratory data published in peer-reviewed medical journals, conducted by cancer researchers in universities and medical research facilities around the world. Some of these studies are still in early stages and include only laboratory or animal data while others have advanced to include human volunteers. We organized these data into the major categories of specific chemotherapy drugs. Within each section for a specific drug are found the research on combinations of that drug with various antioxidants, grouped by the name of the antioxidant in alphabetical order. We also point out specifically which studies were conducted in a laboratory (i.e. used cancer cell cultures), used animals, or involved human volunteers. As each antioxidant appears in the paper for the first time, we provide some introduction to the antioxidant including what food sources naturally contain it, other common applications in clinical use, and typical dosages. The dosages given are not necessarily appropriate for all patients and should be individualized with practitioner guidance.

Click here for the rest of the article